15:58 May 29

Glenmark Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
2274.90
-110.00 (-4.61%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Glenmark Pharmaceuticals Ltd. Financials

Glenmark Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
2274.90
-110.00 (-4.61%)
15:58 May 29
Quality
image/svg+xml

86/100
High Financial Strength

Valuation
image/svg+xml

38/100
Mid Valuation

Technical

59/100
Technically Neutral

Strength

5

Weakness

6

Opportunity

1

Threats

1

12.95 %

ROE %

6.84 %

ROA %

48.26

EPS

372.51

BVPS

8.01 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales
12304.9 12990.11 11813.1 13321.74 16982.51
Operating Expenses +
9984.6 10711.74 10617.76 10970.36 12410.1
Raw Material
4396.42 4862.05 4608.99 4567.27 5358.1
Increase Decrease in Cost
-11.14 -325.09 -195.62 -213.93 -610.64
Other Manufacturing Expense
74.42 0 0 89.54 0
Employee Cost
2447.42 2780.96 2868.14 3022.06 3577.85
Miscellaneous Expenses
5312.8 5930.34 6238.59 6637.42 8878.07
Operating Profit
2320.3 2278.37 1195.34 2351.38 4572.41
Other Income
166.67 316.79 839.99 113.72 460.62
Depreciation
486.72 611.27 581.91 486.01 573.48
Interest
298.1 349.58 515.97 207.06 208.72
Profit before tax and exceptio..
1702.16 1634.3 937.45 1772.03 4250.83
Exceptional Items
-260.91 -765.85 -900.96 -372.82 -2266.08
PBT
1441.25 868.45 36.5 1399.21 1984.75
Provision for Taxation
447.6 491.05 1867.34 352.07 622.79
Net Profit
993.65 377.4 -1433.52 1047.14 1361.95
NET Profit after MI
941.71 297.24 -1501.67 1047.1 1361.85
EPS
33.37 10.53 -53.22 37.11 48.26
Operating Profit Margin (%)
18.86 17.54 10.12 17.65 26.92
Net Profit Margin (%)
7.65 2.29 -12.71 7.86 8.02

Glenmark Pharmaceuticals Ltd. Shareholding

All Data in Percentage (%)

Promoter - - - - -
FII - - - - -
Public - - - - -
MF - - - - -
Others
Shareholder Shares Holding %
Download Our App On: